Image of Emma O'Dowd

Emma O'Dowd

Clinical Associate Professor in Respiratory Medicine, Faculty of Medicine & Health Sciences

Personal Details
Research
Publications

Contact

workRoom B21 Clinical Sciences Building
Nottingham City Hospital
Hucknall Road
Nottingham
NG5 1PB
UK
mczelo@nottingham.ac.uk

Biography

Dr Emma O'Dowd is an honorary consultant respiratory physician at Nottingham University Hospitals NHS Trust and associate clinical professor in respiratory medicine at University of Nottingham. She was awarded a PhD entitled Factors influencing the diagnosis and subsequent prognosis in patients with lung cancer in April 2017 funded by the Roy Castle Lung Cancer Foundation. Her research interests are lung cancer screening and early diagnosis of lung cancer. She is chair of the British Thoracic Society Lung Cancer & Mesothelioma Advisory Group, member of the Lung Cancer Clinical Expert Group and the IASLC Tobacco Control and Smoking Cessation Committee.

Expertise Summary

Lung cancer screening.

Interventional procedures.

Research Summary

SELECT Selection of Eligible People for Lung Cancer Screening using Electronic Primary Care DaTa: Development of new risk prediction models. £358,737. Cancer Research UK. 2018-2024.… read more

Recent Publications

O'DOWD, E, BEROVIC, M and CALLISTER, M ET AL, 2024. Determining the impact of an artificial intelligence tool on the management of pulmonary nodules detected incidentally on CT (DOLCE) study protocol: a prospective, non-interventional multicentre UK study BMJ Open.
2023. Risk of COVID-19 death for people with a pre-existing cancer diagnosis prior to COVID-19-vaccination: A systematic review and meta-analysis. Int J Cancer.
2023. Impact of the SARS-CoV-2 pandemic on lung cancer survival in England: an analysis of the rapid cancer registration dataset Thorax.
2023. ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on management of incidental findings from low dose CT screening for lung cancer ERJ.

View all publications

Current Research

SELECT Selection of Eligible People for Lung Cancer Screening using Electronic Primary Care DaTa: Development of new risk prediction models. £358,737. Cancer Research UK. 2018-2024. Co-applicant
4-IN-THE-LUNG-RUN Towards INdividually tailored INvitations, screening INtervals, and INtegrated co-morbidity reducing strategies in lung cancer screening): A Randomised Comparison of Personalised Lung Cancer Screening Regimens. €7,999,787. Horizon 20:20. 2020-2024. Co-applicant (€400,000 to Nottingham)
DECLINE: DEcisions against Curative treatment for Lung cancer IN Eligible patients. £210,810. Roy Castle Lung Cancer Foundation. 2020-2024. Principal applicant
Use of virtual reality to deliver prehabilitation in patients undergoing lung cancer surgery. £144,000. NHSX. 2022-2024. Co-Principal applicant
Determining the impact of CT analysis software on lung nodule diagnosis (DOLCE). £1,479,044. NHSX AI. 2022-2025. Co-applicant
Phase IV AI. Horizon Europe/ UKRI. Euro 7998990. (Euro 389363 to NUH). Co-applicant. 2023- 2026.

O'DOWD, E, BEROVIC, M and CALLISTER, M ET AL, 2024. Determining the impact of an artificial intelligence tool on the management of pulmonary nodules detected incidentally on CT (DOLCE) study protocol: a prospective, non-interventional multicentre UK study BMJ Open.
2023. Risk of COVID-19 death for people with a pre-existing cancer diagnosis prior to COVID-19-vaccination: A systematic review and meta-analysis. Int J Cancer.
2023. Impact of the SARS-CoV-2 pandemic on lung cancer survival in England: an analysis of the rapid cancer registration dataset Thorax.
2023. ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on management of incidental findings from low dose CT screening for lung cancer ERJ.
2023. Clinical trials in cancer screening, prevention and early diagnosis (SPED): a systematic mapping review BMC Cancer.
2023. Smoking cessation and lung cancer: never too late to quit Lancet Public Health.
2023. Developing a Pan-European Technical Standard for a Comprehensive High-quality Lung Cancer CT Screening Program. An ERS Technical Standard ERJ.
2023. Defining the road map to a UK national lung cancer screening programme Lancet Oncol.
2023. Brain imaging in lung cancer staging: A real-world, multi-centre study of prevalence of brain metastases, impact on treatment and re-modelling of the NICE health economic analysis Lung Cancer.
2023. Lung nodules: sorting the wheat from the chaff The British Journal of Radiology.
2023. The Impact of COVID-19 on Lung Cancer Incidence in England: Analysis of the National Lung Cancer Audit 2019 and 2020 Rapid Cancer Registration Datasets Chest.
VAN MEERBEECK J, O'DOWD E, WARD B, VAN SCHILL P and SNOECKX A, 2022. Lung Cancer Screening: New Perspective and Challenges in Europe Cancers. 14(9), 2343
MORGAN H, BALDWIN D, HUBBARD R, NAVANI N, WEST D and O'DOWD E, 2022. Ninety-day mortality following lung cancer surgery: outcomes from the English national clinical outcomes audit Thorax.
BURZIC A, O'DOWD E and BALDWIN D, 2022. The Future of Lung Cancer Screening: Current Challenges and Research Priorities Cancer Manag Res.
BALDWIN D, CALLISTER M, CROSBIE P, O'DOWD E, RINTOUL R, ROBBINS H and STEELE R, 2021. Biomarkers in lung cancer screening: the importance of study design European Respiratory Journal. 57(1),
ALZUBAIDI A, KAUR J, MAHMUD M, BROWN D, HE J, BALL G, BALDWIN D, O'DOWD E and HUBBARD R, 2021. Selecting Lung Cancer Patients from UK Primary Care Data: A Longitudinal Study of Feature Trends Applied Intelligence and Informatics.
MORGAN H, ELLIS L, O'DOWD E, MURRAY R, HUBBARD R and BALDWIN D, 2021. What is the Definition of Cure in Non-small Cell Lung Cancer? Oncol Ther.
BALATA H, RUPAREL M, O'DOWD E, LEDSON M, FIELD J, DUFFY S, QUAIFE S, SHARMAN A, JANES S, BALDWIN D, BOOTON R and CROSBIE P, 2021. Analysis of the baseline performance of five UK lung cancer screening programmes Lung Cancer. 136-140
O'DOWD E, TEN HAAF K, KAUR J, DUFFY S, HAMILTON W, HUBBARD R, FIELD J, CALLISTER M, JANES S, DE KONING H, RAWLINSON J and BALDWIN D, 2021. Selection of eligible participants for screening for lung cancer using primary care data Thorax.
2021. Lung cancer for the non-respiratory physician Clinical Medicine.
BALDWIN DR, GUSTAFSON J, PICKUP L, ARTETA C, NOVOTNY P, DECLERCK J, KADIR T, FIGUEIRAS C, STERBA A, EXELL A, POTESIL V, HOLLAND P, SPENCE H, CLUBLEY A, O'DOWD E, CLARK M, ASHFORD-TURNER V, CALLISTER ME and GLEESON FV, 2020. External validation of a convolutional neural network artificial intelligence tool to predict malignancy in pulmonary nodules. Thorax. 75(4), 306-312
MORGAN H, O'DOWD E, NAIR A and BALDWIN D, 2020. New fissure-attached nodules in lung cancer screening: more practical implications from the NELSON study? Translational Lung Cancer Research.
BALDWIN D, O'DOWD E and TEN HAAF K, 2020. Targeted screening for lung cancer is here but who do we target and how? Thorax. 75(8),
CRISP E, O'DOWD E and BALDWIN D, 2020. Diagnosis and management of malignant pleural mesothelioma Practitioner. 1843
RUPAREL M, QUAIFE SL, DICKSON JL, HORST C, BURKE S, TAYLOR M, AHMED A, SHAW P, SOO MJ, NAIR A, DEVARAJ A, O'DOWD EL, BHOWMIK A, NAVANI N, SENNETT K, DUFFY SW, BALDWIN DR, SOFAT R, PATEL RS, HINGORANI A and JANES SM, 2019. Evaluation of cardiovascular risk in a lung cancer screening cohort. Thorax. 74(12), 1140-1146
O'DOWD E and TEN HAAF K, 2019. Lung cancer screening: enhancing risk stratification and minimising harms by incorporating information from screening results Thorax.
MORGAN H, O'DOWD E and BALDWIN D, 2019. Time to diagnosis key in improving lung cancer outcomes Practitioner. 263, 21-25
HOWARD L, BARDEN S, CONDLIFFE R, CONNOLLY V, DAVIES C, DONALDSON J, EVERETT B, FREE C, HORNER D, HUNTER L, KALER J, NELSON-PIERCY C, O'DOWD E, PATEL R, PRESTON W, SHEARES K and TAIT C, 2018. British Thoracic Society Guideline for the initial outpatient management of pulmonary embolism (PE) Thorax.
HOWARD L, BARDEN S, CONDLIFFE R, CONNOLLY V, DAVIES C, DONALDSON J, EVERETT B, FREE C, HORNER D, HUNTER L, KALER J, NELSON-PIERCY C, O'DOWD E, PATEL R, PRESTON W, SHEARES K and TAIT C, 2018. British Thoracic Society Guideline for the initial outpatient management of pulmonary embolism BMJ Open Resp Res.
O'DOWD EL and BALDWIN DR, 2017. Lung cancer screening-low dose CT for lung cancer screening: recent trial results and next steps. The British journal of radiology. 20170460
O'DOWD EL, MCKEEVER TM, BALDWIN DR and HUBBARD RB, 2016. Place of Death in Patients with Lung Cancer: A Retrospective Cohort Study from 2004-2013. PloS one. 11(8), e0161399
O'DOWD EL, LÜCHTENBORG M, BALDWIN DR, MCKEEVER TM, POWELL HA, MØLLER H, JAKOBSEN E and HUBBARD RB, 2016. Predicting death from surgery for lung cancer: A comparison of two scoring systems in two European countries. Lung cancer (Amsterdam, Netherlands). 95, 88-93
K CUSWORTH, E O'DOWD, R HUBBARD, P BECKETT, M D PEAKE and I WOOLHOUSE, 2015. Variation in lung cancer resources and workload: results from the first national lung cancer organisational audit Thorax.
E O'DOWD and D BALDWIN, 2015. Screening for lung cancer. Br J Hosp Med (Lond). 76(6), C89-93
E O'DOWD, T MCKEEVER, D BALDWIN, S ANWAR, H POWELL, J GIBSON, B IYEN-OMOFOMAN and R HUBBARD, 2015. Author's response: What characteristics of primary care and patients are associated with early death in patients with lung cancer in the UK? Thorax. 70(2), 185
O'DOWD, E.L., MCKEEVER, T.M., BALDWIN, D.R., ANWAR, S., POWELL, H.A., GIBSON, J.E., IYEN-OMOFOMAN, B. and HUBBARD, R.B., 2015. What characteristics of primary care and patients are associated with early death in patients with lung cancer in the UK? Thorax. 70(2), 161-168
E O'DOWD and D BALDWIN, 2014. Early diagnosis pivotal to survival in lung cancer Practitioner. 258(1776), 21-4
D BALDWIN and E O'DOWD, 2014. Next steps and barriers to implementing lung cancer screening with low-dose CT Br J Radiol. 87(1044),
E O'DOWD, M KUMARAN, B PALOMO and D BALDWIN, 2014. Brain metastases following radical surgical treatment of non-small cell lung cancer: is preoperative brain imaging important? Lung Cancer. 86(2), 185-9
W MCNULTY, E O'DOWD and S KEMP, 2012. Diagnostic and therapeutic flexible bronchoscopy in the management of lung cancer Minerva Pneumologica. 51(2), 59-72